UASt regulatory sequences drive expression of an inverted repeat.
Expression of stvGD10796 under the control of Scer\GAL4Mef2.PR leads to defects in larval muscle morphology with regions devoid of F-actin labeled myofibrillar material, and elongated pupae.
Depending on the insertion line used, expression under the control of Scer\GAL4Mef2.PR can result in late larval lethality or late pupal lethality.
Expression under the control of Scer\GAL4pnr-MD237 results in lethality or semi-lethality at the pupal stage, depending on the insertion line used.
Expression under the control of Scer\GAL4pnr-MD237 results in extra bristles on the notum in 50-60% of the Scer\GAL4pnr-MD237 expression domain.
Expression under the control of Scer\GAL4pnr-MD237 results in a colour difference between the central Scer\GAL4pnr-MD237 expression domain of the notum and the surrounding lateral region in 50-60% of the Scer\GAL4pnr-MD237 expression domain.
Expression under the control of Scer\GAL4pnr-MD237 results in the absence of 50-60% of the Scer\GAL4pnr-MD237-expressing area of the notum.
Scer\GAL4Mef2.PR, stvGD10796 has embryonic/larval somatic muscle cell | third instar larval stage phenotype, non-enhanceable by Nuak[+]/Nuak17289
Scer\GAL4Mef2.PR, stvGD10796 has embryonic/larval somatic muscle cell | third instar larval stage phenotype, non-enhanceable by NuakUAS.RD, Scer\GAL4Mef2.PR
Scer\GAL4Mef2.PR, stvGD10796 has embryonic/larval somatic muscle cell | third instar larval stage phenotype, non-suppressible by Nuak[+]/Nuak17289
Scer\GAL4Mef2.PR, stvGD10796 has embryonic/larval somatic muscle cell | third instar larval stage phenotype, non-suppressible by NuakUAS.RD, Scer\GAL4Mef2.PR